文献速递免疫规划

四价重组流感血凝素疫苗SCVC101在恒河猴中的临床前毒性与免疫原性

Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys.
PubMed 文献 · Vaccine · 2026-09-13

本研究在GLP条件下评估四价重组血凝素流感疫苗SCVC101在恒河猴中的毒性与免疫原性。恒河猴分别在第0、3、6周肌肉注射15 μg和45 μg(每株rHA)两个剂量,结果低高剂量组均诱导强特异性结合抗体和中和抗体,未见明显全身毒性或心血管呼吸异常,显示良好安全性和免疫原性。

要点

  • SCVC101含四种流感株HA基因序列,在恒河猴中诱导强结合抗体和中和抗体。
  • 15 μg和45 μg每株rHA剂量组均未观察到明显全身毒性或心血管呼吸异常。
  • 该临床前毒理研究支持SCVC101具有良好的安全性和免疫原性。

核心结论

  • SCVC101在恒河猴中具有良好的安全性特征和强免疫原性。

研究设计与样本

  • 在GLP条件下,恒河猴肌肉注射SCVC101两个剂量(每株rHA 15 μg和45 μg),于第0、3、6周给药。

主要发现

  • 低剂量和高剂量疫苗组均诱导了强特异性结合抗体和中和抗体。
  • 三次给药后未观察到明显全身毒性或心血管和呼吸异常事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SCVC101 is a novel recombinant hemagglutinin (rHA) protein-based quadrivalent seasonal influenza vaccine containing HA gene sequences of A/Wisconsin/588/2019 (H1N1) pdm09-like virus, A/Cambodia/e0826360/2020 (H3N2)-like virus, B/Washington/02/2019 (B/Victoria lineage)-like virus, and B/Phuket/3073/2013 (B/Yamagata). Significant immune responses to influenza viruses induced by SCVC101 were demonstrated in mice, rats, and rhesus monkeys. This study aimed to investigate the toxicity and immunogenicity of SCVC101 in rhesus monkeys. Under Good Laboratory Practice (GLP) conditions, rhesus monkeys received intramuscular administrations of two distinct dose levels (15 μg and 45 μg of rHA per virus strain) during weeks 0, 3, and 6 of the experimental protocol. The results showed that SCVC101 vaccination elicited a strong specific binding antibody and neutralizing antibodies in the low- and high-dose vaccine groups. No significant systemic toxicities or abnormal cardiovascular and respiratory events were observed after three doses of SCVC101 in rhesus monkeys. Therefore, our regulatory toxicology research demonstrates strong immunogenicity and a favorable safety profile of the SCVC101 vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Guo J, Dai C, Huang Y, et al. Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys. Vaccine. 2026. PMID: 42732725. doi:10.1016/j.vaccine.2026.129137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。